EADV 2026: Lebrikizumab improved hand and foot clearance, itch, and pain at 16 weeks versus placebo in a phase 3b atopic dermatitis trial.
News|Articles|September 14, 2005
Chigger Bites in a Young Boy
Author(s)F. Hall Reynolds II, MD, William F. Keenan, MD
This young boy complained of itchy lesions after he spent a day in a semiwooded area. The lesions appear urticarial, but note that the pattern of eruption is over areas of constrictive clothing: the arm of a shirt and the belt.
Advertisement
This young boy complained of itchy lesions after he spent a day in a semiwooded area. The lesions appear urticarial, but note that the pattern of eruption is over areas of constrictive clothing: the arm of a shirt and the belt. This pattern is typical of chigger bites. An oral antihistamine relieves the itching; topical application of crotamiton further eases the pruritus and kills any remaining chiggers.
Advertisement
Related to this article
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
Advertisement
Advertisement
Trending on Patient Care Online
1
5 FDA Decisions for Primary Care to Know from September 2026
2
Fezolinetant Linked to 2.6 Fewer Nighttime Awakenings in Women With Menopausal VMS
3
Switch to Oral Semaglutide Linked to 4.1% Weight Loss at 3 Months in New Study
4
Atrial Fibrillation Stroke Prevention: Expert Guidance for Primary Care Physicians
5